{"id":"W3213131678","doi":"10.1182/blood-2021-148370","title":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hemolysis; Pyruvate kinase deficiency; Placebo; Sickle cell anemia; Anemia; Internal medicine; Hemolytic anemia; Pyruvate kinase; Gastroenterology; Disease; Glycolysis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432312,0.001490938,0.003560886,0.0004354904,0.0006544733,0.001155146,0.0009130943,0.001951116,0.01094696],"category_scores_gemma":[0.001352826,0.00071217,0.001654421,0.0004403482,0.0009597528,0.001129008,0.0003579734,0.003324192,0.00126113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005188462,"about_ca_system_score_gemma":0.001366305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006141441,"about_ca_topic_score_gemma":0.001528723,"domain_scores_codex":[0.9995376,0.0002044171,0.00002848583,0.0001092109,0.00004206233,0.00007832309],"domain_scores_gemma":[0.9993607,0.0001458928,0.0001253061,0.00005253829,0.00007991324,0.0002355423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9564927,0.01510192,0.0005431,0.001684857,0.001509796,0.00007258252,0.00005188277,0.0002677604,0.004476249,0.0001380973,0.001572174,0.01808901],"study_design_scores_gemma":[0.9605384,0.03738803,0.0008707987,0.00002781004,0.0002784395,0.00002065697,0.00001151211,0.0001703604,0.0001404148,0.00006972707,0.0004755395,0.000008349923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529243,0.01758342,0.001943956,0.001789926,0.001785449,0.01645104,0.002766524,0.0004893321,0.004266175],"genre_scores_gemma":[0.9573305,0.007475511,0.003830543,0.004194072,0.0008294977,0.01918578,0.001795561,0.00005530298,0.005303141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01094696,"threshold_uncertainty_score":0.03662121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008237923920311481,"score_gpt":0.2439470165751577,"score_spread":0.2357090926548462,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}